We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current GLABF market cap is 29.03M. The company's latest EPS is CAD -0.0815 and P/E is -4.91.
| Year End 31 January 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 219k | 0 |
| Operating Income | -436k | -4.25M | -5.71M |
| Net Income | -834k | -4.74M | -5.98M |
| Year End 31 January 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 2.53M | 1.42M | 1.88M |
| Total Liabilities | 2.37M | 476k | 1.95M |
| Total Equity | 160k | 944k | -72k |
| Year End 31 January 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | |
| Operating | -320k | -3.87M | -4.51M |
| Investing | 14k | 8k | -505k |
| Financing | 1.19M | 4.14M | 3.94M |
| Market Cap | 29.03M |
| Price to Earnings Ratio | -4.91 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 363.64 |
| Price to Book Ratio | -407.37 |
| Dividend Yield | - |
| Shares Outstanding | 73.33M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 16.58k |
| 52 Week Change | -26.69% |
| 52 Week High | 0.6957 |
| 52 Week Low | 0.284725 |
| Spread (Intraday) | 0.22 (51.81%) |
| Company Name | Gemina Laboratories Ltd (QB) |
| Address |
10th floor, 595 howe street vancouver, british columbia |
| Website | https://www.geminalabs.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
